ArticleeLife2025
Dock-and-lock binding of SxIP ligands is required for stable and selective EB1 interactions.
Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ADNP Functions During Early Brain Development and Their Relevance to ASD and ADNP Syndrome.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
End binding protein 1 (EB1) is a key component of the signalling networks at microtubule plus ends. It contains an N-terminal microtubule-binding CH domain and a C-terminal EBH domain interacting with SxIP-containing sequences of other microtubule plus end tracking proteins (+TIPs). Using a series of SxIP-containing peptides derived from the microtubule-actin cross-linking factor (MACF), we demonstrate that the SxIP motif itself binds to EBH with low affinity, and that the full interaction requires contribution of residues following the SxIP motif. Based on the solution structure and dynamics of the EBH/MACF complex, we propose a two-step 'dock-and-lock' model for the EBH interaction with targets, where the SxIP motif initially binds to a partially formed EBH pocket. This subsequently induces folding of the unstructured C-terminus and transition to a stable complex. We dissect contributions into the binding and design MACF mutations of the post-SxIP region that enhance the affinity by two orders of magnitude, leading to a nanomolar interaction. We verify the enhanced recruitment of the mutated peptide to the dynamic plus ends of MTs in a live-cell experiment. Our model explains EB1's interaction with the SxIP-containing ligands and can be used to design small-molecule inhibitors blocking SxIP interaction with EB1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.